Patent ID: 6869927

Claim:
A pharmaceutical composition, comprising: (a) a polypeptide comprising Ser (69)-Ser (208) of SEQ ID NO:2 in a concentration range of about 0.02 to about 40 mg/ml (w/v); (b) a buffer having a buffering capacity of between about 5.0 and about 8.0 at a concentration range of about 5 mM to about 50 mM; (c) a pharmaceutically acceptable diluent to bring the composition to a designated volume; and (d) a preservative consisting of a mixture of methyl paraben and propyl paraben, wherein said methyl paraben is at a concentration of 0.1% to 0.2% and said propyl paraben is at a concentration of 0.01% to 0.05%, wherein said polypeptide has KGF-2 activity.